HOME >> BIOLOGY >> NEWS
Hydroxyurea therapy improves survival in most severely affected sickle cell patients

-approved drug for the treatment of sickle cell anemia.

In the new long-term "observational" study, patients selected with their physicians whether to continue, start, or stop treatment with hydroxyurea. Seventy-five (25 percent) of the original 299 patients died during the 9-year study. According to study authors, this statistic reflects the severity of the disease as required by the study design, and the high death rate in adults with sickle cell anemia.

Among study participants, the death rate was 28 percent for those with the lowest fetal hemoglobin level compared to a 15 percent death rate for those with the highest level of fetal hemoglobin. Fetal hemoglobin inside red blood cells of sickle cell anemia patients may prevent these cells from becoming sickled and rigid, hallmarks of the inherited disease. Hydroxyurea is believed to stimulate the production of fetal hemoglobin.

The new study also found that patients with 3 or more painful episodes per year during the trial had a 27 percent death rate versus a 17 percent death rate for those with less frequent episodes.

"Hydroxyurea's ability to reduce complications in the sickest patients is strongly connected to lower death rates," said Duane Bonds, M.D., study co-author and project officer for the MSH Patients' Follow-up Study. "These results also confirm that the benefits of hydroxyurea persist. After the original trial ended, we didn't know if the benefits of the drug would be long term," added Bonds. The new study also has important implications for significantly decreasing health care costs, said Bonds. Patients with more severe forms of the disease are seen in the emergency room and are hospitalized more frequently than patients who are less severely affected.

According to lead investigator Dr. Martin Steinberg, who is Director of the Center of Excellence in Sickle Cell Disease at Boston University School of Medicine, the latest research has important implications for
'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
1-Apr-2003


Page: 1 2 3

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2019)... ... February 26, 2019 , ... Circulomics is launching the Short Read ... for long-read sequencing library preparation. , This kit enhances long-read sequencing read lengths ... HMW DNA is not damaged and recovered with high efficiency. Short DNA up to ...
(Date:2/22/2019)... ... February 21, 2019 , ... Clean label food is not ... creating natural foods and beverages. It is quite common to spot consumers running their ... products are not immune to this label scrutiny. , More than ever, meat ...
(Date:2/19/2019)... , ... February 20, 2019 ... ... an agreement that will see Dimensions rolled out across the organization. Dimensions ... data-driven decisions across their business, support strategic planning, and understand past and ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... ... The growth in the number and complexity of regulations as well as quality ... (RI) systems are not keeping with changing ... cheaper. With a diversity of information sources, identifying and analyzing context based intelligence is ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... gold standard solution for preclinical research organizations. It is a low code, ... connected systems and facilities, innovative technology-driven automated data capture and seamless data ...
(Date:3/9/2019)... ... March 07, 2019 , ... ... pioneer in the development and commercialization of high performance, cutting-edge cell analysis platforms ... European CRO with GLP-certified expertise in cardiovascular pharmacology and electrophysiology, are announcing a ...
(Date:2/27/2019)... ... February 27, 2019 , ... Lajollacooks4u ... today, the San Diego-based team-building and cooking events company will be offering a ... Tequila. , This fun-filled, interactive team-building event involves pairing two popular items together ...
Breaking Biology Technology:
Cached News: